Revenue | ₹1.30Cr |
Net Profits | ₹0.13Cr |
Net Profit Margins | -10% |
Novelix Pharmaceuticals Ltd’s revenue fell -53.41% since last year same period to ₹1.30Cr in the Q2 2022-2023. On a quarterly growth basis, Novelix Pharmaceuticals Ltd has generated -9.09% fall in its revenue since last 3-months.
Novelix Pharmaceuticals Ltd’s net profit fell -140.63% since last year same period to ₹0.13Cr in the Q2 2022-2023. On a quarterly growth basis, Novelix Pharmaceuticals Ltd has generated -85.71% fall in its net profits since last 3-months.
Novelix Pharmaceuticals Ltd’s net profit margin fell -187.19% since last year same period to -10% in the Q2 2022-2023. On a quarterly growth basis, Novelix Pharmaceuticals Ltd has generated -104.29% fall in its net profit margins since last 3-months.
The revenue for Novelix Pharmaceuticals Ltd in the Q2 results 2022 was ₹1.30Cr.
The net profit for Novelix Pharmaceuticals Ltd in the Q2 results 2022 was ₹0.13Cr.
The net profit margin for Novelix Pharmaceuticals Ltd in the Q2 results 2022 was -10%.
The revenue for Novelix Pharmaceuticals Ltd in the Q2 results 2021 was ₹2.79Cr.
The net profit for Novelix Pharmaceuticals Ltd in the Q2 results 2021 was ₹0.32Cr.
The net profit margin for Novelix Pharmaceuticals Ltd in the Q2 results 2021 was 11.47%.